Presentation Controversies and Advances 2017

PCSK9 Inhibitors - Are They Worth The Money?

Presenter: Michael J. Blaha

November 16, 2017

REGISTER for free or LOG IN to view this content

PCSK9 Inhibitors - Are They Worth The Money?

Coronary

CAD Pharma

Presentation

Controversies and Advances 2017

Up Next

Presentation Controversies and Advances 2017

Coronary Calcium Scan is Sufficient for the Evaluation of Patients with Low to Intermediate Risk for ACS in the Emergency Department

Presenter: Mattew Budoff

November 17, 2017

More slides +

Presentation Controversies and Advances 2017

PFO Closure - Close Them All?

Presenter: Ted Feldman

November 17, 2017

Presentation Controversies and Advances 2017

Stress SPECT/PET vs. Stress Echo in Patients with Suspected or Known CAD

Presenter: Sean W. Hayes

November 16, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.